Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Kidney Fibrosis
54%
Mouse
45%
Ureter Obstruction
28%
Fibroblast Growth Factor 21
27%
Clusterin
27%
Kidney Disease
27%
Transforming Growth Factor
21%
Alpha-Lipoic Acid
18%
PPAR Agonist
18%
Angiotensin II
18%
Pandemic
18%
Coronavirinae
18%
Coronary Artery Calcification
18%
Autonomic Neuropathy
18%
Randomized Controlled Trial
18%
Glycosylated Hemoglobin
18%
Nucleotide Pyrophosphatase
18%
Rosiglitazone
18%
Glutamine
18%
Atherosclerosis
16%
Neointima
15%
Enzyme-Linked Immunosorbent Assay
13%
Receptor
13%
Hyperplasia
12%
C57BL 6 Mouse
12%
Peroxisome Proliferator Activated Receptor
12%
Hemoglobin A1c
11%
Transforming Growth Factor
11%
Metabolic Syndrome X
10%
Tumor Necrosis Factor
10%
Injury
10%
Differentiated Thyroid Cancer
10%
Disease
10%
Diabetes Mellitus
10%
Obstruction-Induced Renal Fibrosis
10%
Vascular Cell Adhesion Molecule 1
10%
Platelet Derived Growth Factor
9%
Diabetes Mellitus
9%
6 Diazo 5 Oxonorleucine
9%
Reactive Oxygen Metabolite
9%
Prevalence
9%
Lactate Dehydrogenase
9%
Pyruvate Dehydrogenase Kinase 4
9%
Liver Cell Carcinoma
9%
Adhesive Agent
9%
Acute Coronary Syndrome
9%
Methionine
9%
Phosphodiesterase I
9%
Octreotide
9%
Medicine and Dentistry
Vascular Smooth Muscle Cell
52%
Patient with Type 2 Diabetes
51%
Diabetes Mellitus
35%
Diabetes
33%
Maturity Onset Diabetes of the Young
31%
Lipoic Acid
29%
FGF21
27%
Prevalence
21%
Odds Ratio
21%
Gene Expression
18%
Fibronectin
18%
Thyroid Gland
18%
Aquaporin 2
18%
Transforming Growth Factor
18%
Inpatient
18%
Nephropathy
18%
Coronary Artery Calcification
18%
Steatohepatitis
18%
Nephrogenic Diabetes Insipidus
18%
Randomized Controlled Trial
18%
Urinary System
18%
Cardiovascular System
18%
Methionine/Choline Deficient Diet
18%
Impaired Glucose Tolerance
15%
Tumor Necrosis Factor
13%
Atherosclerosis
12%
Metabolic Syndrome
11%
Injury
11%
Alpha-Linolenic Acid
11%
Differentiated Thyroid Cancer
10%
Cancer
10%
Vascular Cell Adhesion Molecule 1
10%
C57BL/6
9%
Diabetic Nephropathy
9%
Endocrinology
9%
Transforming Growth Factor
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Nuclear Factor
9%
Reactive Oxygen Species
9%
Targeted Therapy
9%
Angiotensin II
9%
Cilostazol
9%
Chronic Kidney Disease
9%
Thyrotropin
9%
Pyruvate Dehydrogenase Kinase 4
9%
Blood Vessel Injury
9%
Neointima
9%
Carotid Artery
9%
Symptom
9%
Growth Differentiation Factor 15
9%
Biochemistry, Genetics and Molecular Biology
Gene Polymorphism
36%
Cell Proliferation
30%
Gene Expression
25%
Creatinine
25%
Rosiglitazone
21%
Prevalence
18%
Proteomics
18%
Cell Migration
18%
Bone Density
18%
Postmenopause
18%
Aquaporin 2
18%
Randomized Controlled Trial
18%
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1
18%
Glutamine
18%
Sodium Urine Level
18%
3T3-L1
18%
Hepatic Stellate Cell
18%
Oxidative Phosphorylation
18%
Glucose Blood Level
16%
Type I Collagen
15%
Single Nucleotide Polymorphism
12%
Peroxisome Proliferator-Activated Receptor
12%
Mouse
12%
Metabolic Pathway
10%
Adenoviridae
10%
Lactate Dehydrogenase
9%
Lactate Dehydrogenase
9%
Impaired Glucose Tolerance
9%
Epstein Barr Virus
9%
Genotyping
9%
Exon
9%
Phospholipase D1
9%
Glucose-6-Phosphate Dehydrogenase
9%
Sorafenib
9%
Tumor Necrosis Factor
9%
Alanine Aminotransferase Blood Level
9%
Plasmid
9%
Matrix Metalloproteinase
9%
Fibroblast Growth Factor
9%
Orphan Nuclear Receptor
9%
Hydroxysteroid Dehydrogenase
9%
Adipocyte
9%
Autophagy
9%
Adipocyte
9%
Autophagy
9%
Gene Therapy
9%
Fibronectin
9%
Transforming Growth Factor
9%
Transforming Growth Factor
9%
Pyruvate Dehydrogenase Kinase
9%